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roﬁlaggrin is a large epidermal polyprotein that is
proteolytically processed during keratinocyte differen-
tiation to release multiple ﬁlaggrin monomer units as
well as a calcium-binding regulatory NH
 
2
 
-terminal ﬁlaggrin
S-100 protein. We show that epidermal deﬁciency of the
transmembrane serine protease Matriptase/MT-SP1 perturbs
lipid matrix formation, corniﬁed envelope morphogenesis,
and stratum corneum desquamation. Surprisingly, proteomic
analysis of Matriptase/MT-SP1–deﬁcient epidermis revealed
P
 
the selective loss of both proteolytically processed ﬁlaggrin
 
monomer units and the NH
 
2
 
-terminal ﬁlaggrin S-100
regulatory protein. This was associated with a profound
accumulation of proﬁlaggrin and aberrant proﬁlaggrin-
processing products in the stratum corneum. The data
identify keratinocyte Matriptase/MT-SP1 as an essential
component of the proﬁlaggrin-processing pathway and a
key regulator of terminal epidermal differentiation.
 
Introduction
 
The epidermis provides a permeability barrier that prevents
excessive water loss to the surrounding environment. To
perform this function, epidermal keratinocytes arise from
proliferating basal cells and move outward through a series
of distinct differentiation events to form the stratum corneum,
a two-compartment structure that consists of a lipid-enriched
ECM in which an interlocking meshwork of dead corneocytes
are embedded (Roop, 1995; Nemes and Steinert, 1999;
 
Presland and Dale, 2000). Epidermal differentiation culminates
with the regulated shedding (desquamation) of the outermost
layer of corneocytes to control the thickness of the stratum
corneum (Egelrud, 2000; Pierard et al., 2000). Water imper-
meability is conferred by the intercorneocyte lipid matrix,
and by an insoluble cornified envelope (CE) that is deposited
on the inner surface of the plasma membrane of the corneo-
cytes. The intercorneocyte lipid matrix consists of a complex
lipid mixture that self-assembles into an ordered multilayer
structure known as lipid lamellae (Landmann, 1986; Elias
and Menon, 1991; Wertz, 2000). These lipids are synthesized
during the final stages of epidermal differentiation by
ubiquitously expressed and epidermis-specific lipid biogenesis
enzymes (Elias and Menon, 1991; Wertz and van den
Bergh, 1998).
The CE is assembled from an array of epidermis-specific
proteins that are coordinately expressed during late stages
of epidermal differentiation, and are linked together by
N
 
 
 
-(
 
 
 
-glutamyl)-lysine isopeptide bonds. Furthermore, a
monomolecular layer of ceramides is covalently attached to
the outer surface of the CE to form a hydrophobic lipid
envelope that covers each corneocyte and provides continuity
with the lipid matrix (Swartzendruber et al., 1987; Wertz
et al., 1989; Marekov and Steinert, 1998).
Profilaggrin is a major epidermal proprotein that under-
goes extensive proteolytic modification during terminal dif-
ferentiation. It is synthesized as a large (
 
 
 
300 kD), ex-
tremely insoluble phosphoprotein that consists of a unique
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NH
 
2
 
-terminal Ca
 
2
 
 
 
-binding protein of the S-100 family,
linked to 10–20 tandem filaggrin monomer repeats (Roth-
nagel and Steinert, 1990; Presland et al., 1992; Zhang et
al., 2002). During terminal epidermal differentiation, the
linker regions connecting the NH
 
2
 
-terminal S-100 protein
and each individual filaggrin repeat are completely removed
by proteolysis to generate two major products: mature filag-
grin monomer and the NH
 
2
 
-terminal S-100 protein (Res-
ing et al., 1984; Presland et al., 1997). Four different func-
tions have been described for these profilaggrin-processing
products: (1) the filaggrin monomer aids keratin aggrega-
tion during the formation of macrofibril bundles (Dale et
al., 1978); (2) filaggrin monomers are a component of the
CE, and may constitute as much as 10% of total cross-
linked CE protein (Steven and Steinert, 1994); (3) filaggrin
monomer is completely degraded in the uppermost layers of
the stratum corneum to produce a mixture of free modified
hygroscopic amino acids that are important for maintaining
Figure 1. Matriptase/MT-SP1–deficient mice are born with epidermal lipid matrix defects and enlarged CEs. Total epidermal (A) and stratum 
corneum (B) lipids in Matriptase/MT-SP1
 /  (open bars, n   3) and control (solid bars, n   3) neonates (mean weight percentage of total 
lipids   SD). (A) *, P   0.04 and (B) *, P   0.02 (two-tailed t test). (C–F) Ultrastructural appearance of transitional cells (C and D) and stratum 
corneum (E and F) of control epidermis (C and E) and Matriptase/MT-SP1
 /  epidermis (D and F) of ruthenium-stained sections. (C) Lipid 
lamellar bodies with well-aligned lipid stacks (arrows) at the interface between the transitional layer and stratum corneum in control epidermis. 
(D) Rare and poorly formed lamellar bodies (arrow) with wavy, short, and disorganized lipid structures in Matriptase/MT-SP1
 /  epidermis. 
(E) Highly ordered intercorneocyte lipid lamellar membranes (arrow) in control stratum corneum. (F) Poorly formed intercorneocyte lipid 
lamellae in Matriptase/MT-SP1
 /  stratum corneum (arrow). (G) Average surface area of newborn Matriptase/MT-SP1
 /  (open bar, n   70) 
and littermate control (solid bar; n   50) CEs (mean   SD; *, P   0.004; two-tailed t test). The experiment was repeated three times with 
similar results. (H) Morphological appearance of purified CEs from Matriptase/MT-SP1
 /  epidermis (right panel) and littermate control 
epidermis (left panel) visualized by phase-contrast light microscopy. Bars: (C–F) 100 nm, (H) 30  m. 
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epidermal hydration (Scott and Harding, 1986; Rawlings et
al., 1994); and (4) the NH
 
2
 
-terminal filaggrin S-100 pro-
tein translocates to the nucleus after being proteolytically
liberated, and is believed to function as a calcium-depen-
dent transcriptional regulator of genes that are associated
with late stratum corneum differentiation (Pearton et al.,
2002; Zhang et al., 2002).
Two factors have greatly complicated the analysis of profil-
aggrin processing. First, expression of recombinant profilag-
grin is problematic due to its large size and extreme insolubil-
ity. Second, the processing of profilaggrin is difficult to mimic
in cultured keratinocytes because only incomplete processing
can be observed after calcium-induced differentiation (Pear-
ton et al., 2002). However, several proteases, believed to par-
take in profilaggrin processing, have been described. These
include members of the proprotein convertase family (e.g., fu-
rin), calpain-1, and a serine protease of unknown identity
termed profilaggrin endopeptidase 1 (PEP1; Resing et al.,
1993, 1995; Pearton et al., 2001). Furin has been proposed to
cleave the NH
 
2
 
 terminus of profilaggrin, facilitating the re-
lease of the NH
 
2
 
-terminal S-100 protein (Pearton et al.,
2001). In contrast, calpain-1 and PEP1 are both implicated in
the processing of the linker regions between the filaggrin
monomer repeats to generate the free filaggrin monomer
(Resing et al., 1993, 1995; Pearton et al., 2001).
Matriptase/MT-SP1 is a novel type II transmembrane
serine protease that is expressed by most cells of epithelial or-
igin, including keratinocytes (Kim et al., 1999; Lin et al.,
1999; Takeuchi et al., 1999; Oberst et al., 2001). Recently,
we demonstrated that a targeted deletion of Matriptase/MT-
SP1 leads to the loss of epidermal barrier function in new-
born mice (List et al., 2002). We now show that kerati-
nocyte-expressed Matriptase/MT-SP1 regulates three key
steps in stratum corneum function—lipid matrix formation,
CE morphogenesis, and desquamation—and we link the
pleiotropic effects of epidermal loss of Matriptase/MT-SP1
to defective proteolytic processing of profilaggrin.
 
Results
 
Matriptase/MT-SP1–deficient mice are born with 
epidermal lipid matrix defects, abnormal CEs, 
and impaired desquamation
 
To understand the barrier function defect caused by Ma-
triptase/MT-SP1 deficiency, lipid matrix, CE formation,
and desquamation were analyzed in neonates (Fig. 1 and
Figure 2. Impaired desquamation of newborn Matriptase/MT-SP1–deficient stratum corneum. (A) Macroscopic appearance of neonatal 
dorsal skin of control (left) and littermate Matriptase/MT-SP1
 /  (right) after 12 sequential applications of adhesive-coated discs. The stratum 
corneum is completely removed from the tape-stripped area of the control epidermis, exposing the lower epidermal layers, whereas only 
minimal defects are apparent in Matriptase/MT-SP1
 /  epidermis subjected to the same treatment. Arrowheads indicate the outline of the 
tape-stripped area. (B) Microscopic appearance of control (left panels) and littermate Matriptase/MT-SP1
 /  (right panels) epidermis before 
(top panels) and after (bottom panels) 12 rounds of tape stripping. Complete removal of the stratum corneum with exposed upper granular 
and transitional cell layers in control mice and minimal stratum corneum removal in Matriptase/MT-SP1
 /  epidermis. Hematoxylin and eosin 
staining. “E” indicates the location of basal and suprabasal epidermis, and “S” indicates the location of the stratum corneum. Bars, 20  m. 
(C) Accumulated removal of extractable stratum corneum proteins from Matriptase/MT-SP1
 /  (open squares, n   7) and littermate control 
(closed circles, n   7) mice after tape stripping (  SEM; *, P   0.03; two-tailed t test). 
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Fig. 2). Interestingly, several distinct changes were detected
in total epidermal (Fig. 1 A) and stratum corneum (Fig. 1 B)
lipids of Matriptase/MT-SP1
 
 
 
/
 
 
 
 neonates. Free fatty acids
were decreased almost 50% in Matriptase/MT-SP1
 
 
 
/
 
 
 
 epi-
dermis, whereas cholesterol was increased by 
 
 
 
25%, and its
derivatives, sterol esters, displayed an almost 10-fold de-
crease (Fig. 1 A). Furthermore, the phospholipid content
was more than doubled in Matriptase/MT-SP1
 
 
 
/
 
 
 
 stratum
corneum, rendering phospholipids a major intercorneocyte
lipid component; other lipids were present in similar pro-
portions to control mice (Fig. 1 B). Ultrastructural analysis
of ruthenium tetroxide–preserved epidermal lipid structures
showed that the abnormal epidermal lipid composition seri-
ously compromised lipid matrix assembly. Compared with
control mice, lamellar bodies were extremely sparse in the
granular layer of neonatal Matriptase/MT-SP1
 
 
 
/
 
 
 
 epidermis
and presented as wavy, short, and disorganized lipid struc-
tures (Fig. 1, C and D). Likewise, the intercorneocyte lip-
ids were poorly organized with short and misaligned lipid
lamellae (Fig. 1, E and F). These data demonstrate that
Matriptase/MT-SP1 is essential for stratum corneum lipid
matrix formation.
CEs were isolated from Matriptase/MT-SP1
 
 
 
/
 
 
 
 neonates
to assess their morphology and mechanical integrity. Inter-
estingly, the Matriptase/MT-SP1
 
 
 
/
 
 
 
 CEs were 15% larger
than the CEs isolated in parallel from littermate controls, re-
vealing a distinct alteration in CE morphogenesis (Fig. 1 G).
However, Matriptase/MT-SP1
 
 
 
/
 
 
 
 CEs displayed no alter-
ations in shape or surface appearance when examined by
light microscopy (Fig. 1 H) or scanning EM (unpublished
data), or a decreased mechanical strength, as measured by
the resistance to ultrasound treatment (unpublished data).
In accordance with the latter observations, the expression
level and the enzymatic activity of transglutaminase-1, -2,
and -3 were unaffected by the loss of Matriptase/MT-SP1
(unpublished data).
Next, we subjected newborn Matriptase/MT-SP1
 
 
 
/
 
 
 
 epi-
dermis to a tape-stripping procedure routinely used to assess
stratum corneum integrity (Marttin et al., 1996; Dreher et
al., 1998). Adhesive-coated discs were repeatedly applied to
the dorsal skin, and stratum corneum removal was analyzed
by visual inspection, histological analysis, and quantitation of
stratum corneum protein loss. The entire stratum corneum of
control mice was lost after 12 successive rounds of tape strip-
ping, leaving the lower layers of the epidermis exposed (Fig.
2, A and B; left panels). However, the same procedure barely
affected the Matriptase/MT-SP1
 
 
 
/
 
 
 
 stratum corneum (Fig.
2, A and B; right panels). This increased mechanical resis-
tance of Matriptase/MT-SP1
 
 
 
/
 
 
 
 epidermis was further evi-
denced by a significant reduction in stratum corneum protein
loss after tape stripping, as determined by the quantitation of
total protein adhering to adhesive-coated discs applied to
Matriptase/MT-SP1 and control skin (Fig. 2 C).
 
Loss of mature filaggrin monomer in neonate 
Matriptase/MT-SP1–deficient epidermis
 
Analysis of newborn Matriptase/MT-SP1
 
 
 
/
 
 
 
 epidermis by
cDNA array hybridization, Western blot analysis, immuno-
histochemistry, or two-dimensional gel electrophoresis did
not unravel significant changes in the expression of epidermal
 
differentiation–associated structural genes (Fig. 3 B; unpub-
lished data). Surprisingly, however, Matriptase/MT-SP1
 
 
 
/
 
 
 
epidermal protein extracts separated by SDS-PAGE lacked a
major protein of 
 
 
 
32 kD (Fig. 3 A, lanes 1 and 2). The 32-
kD protein was not expressed in detectable amounts in the
dermis (Fig. 3 A, lanes 3 and 4) or in a number of tissues that
developed normally in Matriptase/MT-SP1
 
 
 
/
 
 
 
 mice (unpub-
lished data), suggesting that the absence of this protein could
be causally related to the epidermal phenotype in the mutant
mice. To identify the 32-kD protein product, extracts from
Matriptase/MT-SP1
 
 
 
/
 
 
 
 and littermate control epidermis
were separated by preparative SDS-PAGE. Proteins within
the 32-kD size range were then subjected to in-gel tryptic di-
gestion, followed by differential mass spectrometry–based
peptide mapping. This analysis identified six peptides that
were exclusively present in the control epidermis. All six pep-
tides could unambiguously be assigned as being derived from
mouse filaggrin (Table I). This result was confirmed by the
absence of immunoreactive material within the 32-kD range
in Western blot analysis of extracts of Matriptase/MT-SP1
 
 
 
/
 
 
Figure 3. Matriptase/MT-SP1–deficient epidermis lacks proteolyt-
ically processed filaggrin monomer. (A) Amido black staining 
(lanes 1–4) of SDS-PAGE–separated protein extracts from epidermis 
(lanes 1 and 2) and dermis (lanes 3 and 4), and whole-skin extract 
filaggrin monomer Western blot (lanes 5 and 6) of control (lanes 1, 
3, and 5) and littermate Matriptase/MT-SP1
 /  (lanes 2, 4, and 6) 
neonates. (B) Western blot analysis of SDS-PAGE–separated proteins 
from skin from control (lane 1) and littermate Matriptase/MT-SP1
 /  
(lane 2) neonates using antibodies against the basal layer markers 
keratin-5 and -14, the suprabasal layer markers keratin-1 and -10, 
and the granular layer/stratum corneum marker loricrin. (C) Western 
blot analysis of total skin protein extracts from neonates (lanes 1 and 2) 
and E18.5 embryos (lanes 3 and 4) from control (lanes 1 and 3) and 
littermate Matriptase/MT-SP1
 /  (lanes 2 and 4) mice using the filaggrin 
monomer repeat antibody. (D) Western blot of total skin protein 
extracts from newborn control (lane 1), littermate Matriptase/MT-
SP1
 /  (lane 2), Klf4 control (lane 3), and littermate Klf4
 /  (lane 4) 
neonates using the filaggrin monomer repeat antibody. Arrowheads in 
A, C, and D indicate the 32-kD filaggrin monomer immunoreactive 
protein specifically missing in Matriptase/MT-SP1
 /  epidermis. The 
positions of mol wt markers (kD) are indicated. 
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skin using a filaggrin monomer repeat antibody (Fig. 3 A,
lanes 5 and 6). Together, the data show that epidermal
Matriptase/MT-SP1 deletion correlates with the loss of de-
tectable filaggrin monomer in the absence of overt changes in
the expression of other abundant epidermal proteins.
 
Loss of filaggrin monomer is not secondary to the loss 
of epidermal barrier function
 
Two separate strategies were used to determine whether the
loss of filaggrin monomer in Matriptase/MT-SP1
 
 
 
/
 
 
 
 epider-
mis was caused by a compensatory increase in filaggrin turn-
over secondary to the loss of epidermal barrier function
(Scott and Harding, 1986; Rawlings et al., 1994), or if it was
the direct consequence of the loss of Matriptase/MT-SP1.
First, filaggrin expression was analyzed in the epidermis
from embryonic day 18.5 (E18.5) embryos immediately af-
ter delivery by Caesarian section. This procedure excluded
potential effects on filaggrin turnover caused by postpartum
air exposure and dehydration. The 32-kD filaggrin mono-
mer was readily detected in E18.5 control epidermis by
Western blot analysis using a filaggrin monomer repeat anti-
body (Fig. 3 C, lane 3), but was present in substantially
lower amounts than in neonate control skin (Fig. 3 C, lane
1), as reported previously (Hardman et al., 1998). In con-
trast, no filaggrin protein was detected in E18.5 Matriptase/
MT-SP1
 
 
 
/
 
 
 
 epidermis (Fig. 3 C, lane 4), demonstrating
that the loss of filaggrin monomer occurs before birth and
exposure to a dehydrating terrestrial environment. Second,
the expression of filaggrin in neonatal epidermis from Klf4
 
 
 
/
 
 
 
mice was analyzed. These mutant mice display a complete
loss of skin barrier function leading to perinatal death due
to dehydration, and they phenotypically closely resemble
Matriptase/MT-SP1
 
 
 
/
 
 
 
 mice (Segre et al., 1999). However,
Western blot analysis showed normal expression of filaggrin
monomer in the epidermis of newborn Klf4
 
 
 
/
 
 
 
 pups (Fig. 3
D, compare lane 3 with lane 4). Together, the data show
that the loss of filaggrin monomer is not secondary to the
loss of barrier function and epidermal dehydration.
 
Proteolytic processing of profilaggrin is defective 
in Matriptase/MT-SP1–deficient epidermis
 
Profilaggrin accumulates in large quantities in the granular
layer of the epidermis, where it undergoes extensive post-
translational processing by endoproteolytic cleavage in the
 
transitional cell layer to produce the mature filaggrin mono-
mer. To analyze the function of Matriptase/MT-SP1 in
profilaggrin processing, the epidermis from pairs of newborn
Matriptase/MT-SP1
 
 
 
/
 
 
 
 and control pups were subjected to
NaSCN extraction, precipitation, and urea solubilization of
extracted proteins. This extraction procedure results in the
purification of profilaggrin and its proteolytic products to
 
 90% homogeneity (Resing et al., 1984), and permitted a
detailed analysis of profilaggrin processing. Protein extracts
from normal epidermis prepared this way contain predomi-
nantly the 32-kD filaggrin monomer, quantitatively minor
amounts of higher mol wt complexes of filaggrin-processing
intermediates, and profilaggrin, which appear as a regularly
spaced “ladder” of proteins after separation by SDS-PAGE
(Fig. 4 A, lanes 1 and 3; Resing et al., 1984). In striking con-
trast, the 32-kD filaggrin monomer could not be detected in
extracts prepared from Matriptase/MT-SP1
 /  epidermis,
confirming the requirement of the serine protease for filag-
grin monomer generation (Fig. 4 A, lanes 2 and 4). Instead,
these extracts contained highly increased amounts of profil-
aggrin and aberrant filaggrin processing intermediates. The
pronounced accumulation of profilaggrin and the aberrant
profilaggrin-processing products in Matriptase/MT-SP1
 / 
epidermis were not associated with a detectable increase in
profilaggrin mRNA, as determined by both Northern blot
analysis and cDNA array hybridization (unpublished data).
Aberrantly processed profilaggrin products incorporate 
in corneocytes during terminal differentiation of 
Matriptase/MT-SP1–deficient epidermis
Profilaggrin is sequestered in cytoplasmic nonmembrane-
bound insoluble keratohyalin filaggrin granules (F-granules)
in the granular layer, is proteolytically processed and released
from F-granules during terminal differentiation, and is
incorporated into the CEs of corneocytes (Steinert and
Marekov, 1995; Simon et al., 1996). Immuno-EM of Ma-
triptase/MT-SP1
 /  epidermis was used to determine the
ultrastructural location and fate of profilaggrin in the ab-
sence of normal processing. Examination of the F-granules
in the granular layer did not reveal significant changes in the
staining intensity between Matriptase/MT-SP1–deficient
and –sufficient epidermis (Fig. 4, B and C), compatible with
the normal microscopic and ultrastructural appearance of
F-granules (List et al., 2002). In terminally differentiated
Table I. Identification of filaggrin as the protein absent in Matriptase/MT-SP1–deficient skin by mass spectrometry
Measured mass Theoretical mass
a Residue no. Sequence
DD
2461.4 2461.5 117–136 (R)GHQHQHQHQHEHEQPESGHR(Q)
2197.1 2197.3 206–226 (R)QPSPSQSSDSQVHSGVQVEGR (R)
2354.3 2353.5 206–227 (R)QPSPSQSSDSQVHSGVQVEGRR (G)
2721.9 2721.5 202–226 (R)DRPRQPSPSQSSDSQVHSGVQVEGR (R)
2632.6 2632.6 45–70 (R)GVSESQASDSEGHSDFSEGQAVGAHR (Q)
2788.2 2788.8 44–70 (R)RGVSESQASDSEGHSDFSEGQAVGAHR(Q)
Skin lysates from newborn Matriptase/MT-SP1
 /  mice and littermate controls were separated by SDS-PAGE, and proteins were stained with amido black.
Two corresponding gel pieces, in the region where a major protein appeared to be absent in the Matriptase/MT-SP1
 /  mice, were excised from parallel
lanes containing skin lysates from Matriptase/MT-SP1
 /  mice and control mice, and were subjected to in-gel trypsin digestion. The fragments listed represent
peptides that were prominent in the control skin and were nondetectable in the Matriptase/MT-SP1
 /  skin.
aTheoretical average masses were derived from the National Center for Biotechnology Information database identifying mouse filaggrin B (GenBank/EMBL/DDBJ
accession no. B35026).906 The Journal of Cell Biology | Volume 163, Number 4, 2003
corneocytes, filaggrin-immunoreactive material was profuse
in the central and peripheral keratin aggregates in both Ma-
triptase/MT-SP1
 /  and control epidermis (Fig. 4, D and
E). In conclusion, the data suggest that unprocessed or aber-
rantly processed profilaggrin is released from F-granules and
incorporates into terminally differentiated corneocytes.
Matriptase/MT-SP1 deficiency impairs proteolytic 
liberation of profilaggrin S-100 protein
The sequential proteolytic liberation of the NH2-terminal
filaggrin S-100 protein is required for its nuclear transloca-
tion during terminal epidermal differentiation (Pearton et
al., 2002). Western blot analysis of epidermal extracts from
control mice using a peptide antibody directed against the
NH2-terminal A domain of the profilaggrin S-100 protein
revealed the mature S-100 protein as well as several process-
ing intermediates that have been characterized previously
(Fig. 5, lane 1). These included doublet proteins of 28–30
kD, corresponding to the intact, proteolytically liberated
S-100 protein, and a 16-kD protein, corresponding to the iso-
lated A domain (Presland et al., 1997; Pearton et al., 2002).
Interestingly, parallel analysis of epidermis from Matriptase/
MT-SP1
 /  littermates demonstrated the absence of both
the proteolytically liberated S-100 protein and the isolated A
domain. This was associated with the dramatic accumula-
tion of a 50-kD protein previously identified as the intact
S-100 protein linked to the first truncated filaggrin repeat
(Fig. 5, lane 2; Pearton et al., 2002). This protein product
was previously identified as a proteolytic processing interme-
diate that is rapidly converted into the mature S-100 protein
in the normal epidermis, indicating that Matriptase/MT-
SP1 is required for this specific processing step. An immu-
Figure 4. Defective proteolytic processing of profilaggrin and incorporation of aberrantly processed profilaggrin into the stratum corneum 
of Matriptase/MT-SP1–deficient epidermis. (A) Profilaggrin (Pro-FG) and profilaggrin-derived (FG) proteins were partially purified by NaSCN 
and urea extraction of the skin of control (lanes 1 and 3) and littermate Matriptase/MT-SP1
 /  (lanes 2 and 4) neonates. 50 (lanes 1 and 2) or 
0.5 (lanes 3 and 4)  g protein was separated by SDS-PAGE under reducing conditions and stained with Coomassie brilliant blue (lanes 1 and 2) 
or subjected to Western blot analysis with a filaggrin monomer antibody (lanes 3 and 4). The positions of profilaggrin-related protein products 
are indicated on the left, and the positions of mol wt markers (kD) on the right. (B–E) Representative examples of filaggrin immuno-EM of 
filaggrin granules (F) in granular layer cells (B and C), and corneocytes (“c” in D and E) from littermate control (B and D) and Matriptase/MT-
SP1
 /  (C and E) epidermis. Filaggrin antibody binding was visualized with colloidal gold-labeled secondary antibodies. Both filaggrin granules 
in granular layer cells (B and C) and keratin aggregates of terminally differentiated corneocytes (D and E, arrowheads) display intense gold 
labeling, indicative of incorporation of profilaggrin immunoreactive material, with no detectable differences in the labeling intensity in control 
and Matriptase/MT-SP1
 /  epidermis. Bars: (B and C) 100 nm, (D and E) 75 nm.
Figure 5. Loss of proteolytic liberation of NH2-terminal filaggrin 
S-100–containing protein products in Matriptase/MT-SP1–deficient 
epidermis. Western blot analysis of epidermal protein extracts from 
control (lane 1) and littermate Matriptase/MT-SP1
 /  (lane 2) neonates 
stained with the filaggrin S-100 A domain antibody. Control epidermis 
contains mature S-100 protein (28- and 30-kD doublets) and the 
isolated 16-kD S-100 A domain. In contrast, Matriptase/MT-SP1
 /  
epidermis contains no detectable S-100 protein, a dramatic accumu-
lation of the 50-kD processing intermediate, and accumulation of 
an unidentified 10-kD filaggrin-related protein product. “A” and “B” 
indicate the A and B domains of the filaggrin S-100 protein, “TGF” 
indicates the truncated filaggrin repeat, and “FG 1” indicates the 
first filaggrin repeat.Membrane serine protease in barrier function | List et al. 907
noreactive 10-kD protein was also uniquely present in
Matriptase/MT-SP1
 /  epidermis, possibly representing the
isolated EF hands of the A domain, formed as a consequence
of impaired proteolytic liberation of the S-100 domain (Fig.
5, lane 2). The data show that loss of epidermal Matriptase/
MT-SP1 impairs the proteolytic liberation of the NH2-ter-
minal filaggrin S-100 protein.
Prolonged exposure of Matriptase/MT-SP1–deficient 
skin to dehydration leads to severe ichthyosis
To determine if the epidermal barrier defect in Matriptase/
MT-SP1
 /  mice was caused by a transient and correctable
delay in epidermal development or whether it could be res-
cued by systemic expression of Matriptase/MT-SP1, whole
skin from Matriptase/MT-SP1
 /  and littermate control
neonates was transplanted to adult athymic nude mice. 3
wk after transplantation, the control grafts were covered
with hair (Fig. 6 A, left), whereas skin from Matriptase/
MT-SP1
 /  mice presented with grotesque epidermal
thickening and the formation of large plate-like epidermal
scales (Fig. 6 A, right). Histologically, the grafted skin from
control mice displayed a thin (2–3 cell layers) epidermis
(Fig. 6 B) with low proliferation of basal keratinocytes (Fig.
6 D), characteristic of young adult skin. In stark contrast,
transplanted Matriptase/MT-SP1
 /  skin developed severe
epidermal acanthosis (10–12 cell layers) and hyperkeratosis,
with the formation of an extremely thick, compact stratum
corneum (Fig. 6 C), pronounced hyperproliferation of basal
keratinocytes as determined by BrdU incorporation (Fig.
6 E), and expression of the hyperproliferation-associated
marker, keratin-6 (Fig. 6, compare F with G; Weiss et al.,
1984). In contrast to control skin, erupted pelage hairs
were almost absent in transplanted Matriptase/MT-SP1
 / 
skin (Fig. 6 A, right). Scanning EM examination of Ma-
triptase/MT-SP1
 /  skin occasionally revealed a few pelage
hair shafts that uniformly presented as thin, broken fibers
surrounded by dense sheaths of cornified debris (unpub-
lished data). Matriptase/MT-SP1
 /  epidermis displayed a
profuse accumulation of aborted pelage hair follicle rem-
nants embedded within the stratum corneum and a follicu-
lar infundibulum that was plugged by cornified material
(unpublished data). Together, these data show that sys-
temic expression of Matriptase/MT-SP1 does not correct
the epidermal defects in Matriptase/MT-SP1
 /  skin, and
demonstrate a continuous requirement for keratinocyte
Matriptase/MT-SP1 in epidermal differentiation.
Discussion
This paper demonstrates that the loss of keratinocyte
Matriptase/MT-SP1 precipitates a plethora of defects in stra-
tum corneum formation that compound to cause a cata-
Figure 6. Prolonged exposure of transplanted Matriptase/MT-SP1 epidermis to air leads to severe hyperproliferative ichthyosis. Gross (A) 
and microscopic (B–G) appearance of control (B, D, and F) and Matriptase/MT-SP1
 /  (C, E, and G) skin, 3 wk after transplantation to nude 
mice. Sections were stained with hematoxylin and eosin (B and C), or by immunostaining with anti-BrdU (D and E) or keratin-6 (F and G) 
antibodies. (A) Alopecia, grotesque epidermal thickening, and formation of epidermal plates in transplanted Matriptase/MT-SP1
 /  skin. 
(B–G) Profound acanthosis and hyperkeratosis of transplanted Matriptase/MT-SP1
 /  skin (compare B with C) with epidermal hyperproliferation 
(compare D with E) and keratin-6 overexpression (compare F with G). “E” in B and C indicates the location of basal and suprabasal epidermis, 
and “S” indicates the location of the stratum corneum. Examples of proliferating keratinocytes in the hair follicles (arrows) in D and in the 
epidermis in E are indicated with arrowheads. Keratin-6 staining of hair follicles (but not epidermis) in F, compared with strong keratin-6 
staining of both epidermis and hair follicles in G. Bars, (B–G) 20  m.908 The Journal of Cell Biology | Volume 163, Number 4, 2003
strophic loss of epidermal barrier function. The formation of
the stratum corneum lipid matrix, CE morphogenesis, and
desquamation were all shown to be Matriptase/MT-SP1–
dependent. These defects correlated at the molecular level with
the loss of the capacity to adequately proteolytically process
epidermal profilaggrin, but not with detectable alterations in
appearance of a range of other epidermal proteins, or with the
proteolytic processing of epidermal transglutaminases. This
specific proteolytic deficiency led to the selective loss of two
prominent stratum corneum proteins, filaggrin monomer and
filaggrin S-100 protein. The epidermal deficiency was not cor-
rected with time or by systemic expression of Matriptase/MT-
SP1, and prolonged exposure of barrier-deficient Matriptase/
MT-SP1
 /  skin to a dehydrating environment lead to the
development of compensatory hyperproliferative ichthyosis.
Previous experiments have established clear links between
defects in filaggrin and congenital ichthyosis, suggesting a di-
rect causal relationship between Matriptase/MT-SP1 defi-
ciency, loss of profilaggrin processing, and impaired barrier
function. The flaky tail (ft) mouse mutant has lost the capac-
ity to encode about half of the filaggrin monomer repeats,
but not the S-100 protein (Presland et al., 2000). Newborn
ft/ft mice present with an epidermal phenotype that is simi-
lar to (but somewhat milder than) Matriptase/MT-SP1 defi-
ciency. The ft/ft phenotype includes dry, scaly skin with
orthokeratotic hyperkeratosis. In humans, ichthyosis vulgaris
is a heterogeneous and relatively common skin disorder with
both autosomal dominant and recessive inheritance patterns
(Francis, 1994; Compton et al., 2002). The clinical manifes-
tations vary from mild to disfiguring scaling with painful fis-
suring, and at least some forms of the disease are associated
with a reduction of profilaggrin expression, with the level of
profilaggrin expression having been reported to correlate in-
versely with disease severity (Sybert et al., 1985). Harlequin
ichthyosis is the most severe form of human congenital ich-
thyosis described thus far. Individuals affected by this rare
autosomal recessive disorder usually die within the first few
weeks of life and present with malformation of the stratum
corneum, severely compromised epidermal barrier function,
and large plate-like epidermal scales (Williams, 1992; Ak-
iyama, 1999). Harlequin ichthyosis has been divided into
three subtypes (I–III), based in part on the status of profilag-
grin and filaggrin processing (Dale et al., 1990). Patients
with type III disease lack detectable profilaggrin, whereas pa-
tients with type I and II disease have normal profilaggrin, but
loss of proteolytic processing of profilaggrin. The epidermal
defects in Harlequin ichthyosis patients also share several
other features of Matriptase/MT-SP1–deficient mouse skin.
These include hyperkeratosis, acanthosis, keratin-6 overex-
pression, lipid matrix defects, and impaired desquamation,
but normal keratin-1, -5, -10, -14, loricrin, and transglutam-
inase expression (Hashimoto and Khan, 1992; Dale and
Kam, 1993; Hashimoto et al., 1993; Nashi et al., 1993). In
the light of these data, it is tempting to speculate that either
the loss of filaggrin monomer and filaggrin S-100 protein
from the upper epidermis or the incorporation of aberrantly
processed profilaggrin into the stratum corneum may repre-
sent the central molecular event that precipitates the sub-
sequent pleiotropic effects of Matriptase/MT-SP1 defi-
ciency on epidermal development. Matriptase/MT-SP1 is the
fourth protease to be implicated specifically in the complex
series of proteolytic processing events that leads to the gener-
ation of filaggrin monomer and the filaggrin S-100 protein.
Many molecular aspects of profilaggrin processing are still in-
completely understood, due to the very peculiar properties of
the profilaggrin protein (extreme insolubility and inability to
be expressed as a recombinant protein) and the inability to
mimic profilaggrin processing in cultured keratinocytes (see
Introduction). This complex process includes multiple sepa-
rate proteolytic cleavage events between the truncated filag-
grin repeat and the first complete filaggrin repeat, between
the S-100 protein and the first filaggrin repeat, the initial en-
doproteolytic cleavages of linker regions between filaggrin
monomer repeats, and additional exo- or endoproteolytic
trimming of the residual linker peptides. Terminal differenti-
ation of keratinocytes is associated with dramatic changes in
intracellular organelles and the plasma membrane that lead
to cytoplasmic access of proteins normally located in the lu-
men of intracellular organelles or on the cell surface (Pearton
et al., 2002). Pericellular, organelle-associated, and cytoplas-
mic proteases could therefore all potentially participate in the
processing of profilaggrin. Matriptase/MT-SP1, although
normally a cell surface–associated protease, could therefore
have both direct functions in profilaggrin processing (profil-
aggrin cleavage and activation of profilaggrin-processing en-
zymes) and indirect functions (growth factor activation,
ectodomain shedding, and ECM remodeling). With respect
to the first possibility, it should be noted that the specific
cleavage site between the truncated filaggrin repeat and the
first filaggrin repeat in both mouse and human profilaggrin
resembles the Matriptase/MT-SP1 consensus cleavage site
defined previously (Takeuchi et al., 2000; Zhang et al.,
2002), and that this cleavage of profilaggrin was clearly
retarded in the Matriptase/MT-SP1
 /  epidermis. The Ma-
triptase/MT-SP1 consensus cleavage site is as follows:
P4-(Arg/Lys)P3-(X)P2-(Ser)P1-(Arg)P1 -(Ala) or P4-(X)P3-
(Arg/Lys)P2-(Ser)P1(Arg)P1 -(Ala). The mouse profilaggrin
cleavage site is as follows: P4-(Arg)P3-(Arg)P2-(Ser)P1-
(Arg)P1 -(Ala). The human profilaggrin cleavage site is as
follows: (P4-(Arg)P3-(Lys)P2-(Arg)P1-(Arg)P1 -(Gly).
Matriptase/MT-SP1–deficient mice display hair follicle,
hair canal, and thymic defects in addition to the loss of epi-
dermal barrier function (List et al., 2002). It is noteworthy
that profilaggrin is expressed in both follicular epidermis and
thymic epithelium (Dale et al., 1985; Favre, 1989), and it is,
therefore, quite possible that the loss of profilaggrin process-
ing is the common molecular etiology of follicular, interfol-
licular, and thymic defects in Matriptase/MT-SP1
 /  mice.
In conclusion, the data presented in these experiments
have identified Matriptase/MT-SP1 as a novel and essential
component of the profilaggrin-processing pathway and a key
enzyme in terminal epidermal differentiation.
Materials and methods
Mice
Mice were generated and genotyped as described previously (Segre et al.,
1999; List et al., 2002). The analysis of Matriptase/MT-SP1
 /  mice was per-
formed on two independent mouse strains, generated either as described
previously (List et al., 2002) or by replacing exon 2 of Matriptase/MT-SP1
with a neomycin transferase expression cassette in E14.1 embryonic stemMembrane serine protease in barrier function | List et al. 909
cells. In all experiments, pairs of Matriptase/MT-SP1
 /  and littermate con-
trol (Matriptase/MT-SP1
 /  and 
 / ) mice were used. Athymic nude-nu mice
were purchased from Harlan. The experiment was performed in accor-
dance with guidelines from the National Institutes of Health.
Histological and immunohistochemical analysis of epidermis
Histological and immunohistochemical analysis was performed as de-
scribed previously (List et al., 2002). Tissue sections were stained with an-
tibodies against keratin-1, -5, -6, -10, -14, and -16, loricrin, antibodies rec-
ognizing part of the filaggrin monomer repeat (DSQVHSGVQVEGRRGH;
Covance), or the A domain of the NH2-terminal S-100 protein (aa 38–52 in
human profilaggrin; Zymed Laboratories). Cell proliferation was visualized
by i.p. injection of 100  g/g BrdU (Sigma-Aldrich) for 2 h before euthana-
sia and staining with anti-BrdU antibodies (DakoCytomation). Bound anti-
bodies were visualized with a Vectastain
® ABC peroxidase kit (Vector Lab-
oratories) using DAB as the chromogenic substrate.
Immuno-EM
60-nm fixed tissue sections, generated as described previously (List et al.,
2002), were placed on nickel grids, incubated in 50 mM glycine in PBS for
15 min, blocked in PBS with 5% BSA/5% goat serum and 0.1% cold water
fish gelatin for 15 min, and in PBS with 0.1% Aurion BSA-C (Electron Mi-
croscopy Sciences) twice for 5 min. The sections were incubated with 10
 g/ml primary antibody in the above PBS/Aurion BSA-C for 1 h, washed
six times for 5 min in PBS/Aurion BSA-C, and incubated in a 1:40 dilution
of 6-nm gold–conjugated goat anti–rabbit IgG antibody (Electron Micros-
copy Sciences) in PBS/Aurion BSA-C for 1 h. Sections were washed six
times for 5 min each with buffer, twice for 5 min each in PBS, fixed in 2%
glutaraldehyde in PBS for 5 min, washed twice for 5 min in water, stained
in uranyl acetate and lead citrate, and viewed under an electron micro-
scope (model 100 CX-II; JEOL).
Ruthenium tetroxide transmission EM
The skin samples were processed essentially as described previously (Elias
et al., 1998). In brief, 1-mm pieces were fixed overnight in 2.5% glutaral-
dehyde and 2% PFA in 0.1 M sodium cacodylate buffer, pH 7.4, at 4 C.
The samples were post-fixed with 1% OsO4 for 2 h in the dark and were
incubated in 0.25% ruthenium tetroxide for 45 min, followed by dehydra-
tion and embedding. The blocks were polymerized at 68 C for 48 h. 80–
90-nm “near-surface” sections were mounted on copper grids, stained
with uranyl acetate and lead citrate, and examined with a transmission
electron microscope (model 1010; JEOL) operated at 80 kV.
Tape stripping of epidermis
Neonates were killed by CO2 inhalation, and the dorsal skin area was
sequentially stripped with 14-mm D-Squame disks (Cuderm Corpora-
tion). The removed protein was quantitated as described previously
(Dreher et al., 1998).
Preparation of CEs
CEs were purified and sonicated at 10 or 30 C for 30 min in a bath sonica-
tor exactly as described previously (Koch et al., 2000).
Tissue protein extraction
Organs were homogenized on ice in 2% SDS, 10% glycerol, and 62.5 mM
Tris-HCl, pH 6.8, sonicated three times for 15 s with a probe sonicator, and
the lysate was cleared by centrifugation at 10,000 g for 10 min at 4 C. Neo-
natal epidermis was separated from dermis with forceps after heating the skin
at 50 C for 3 min in PBS with 10 mM EDTA. Filaggrin and its precursors were
purified from epidermis exactly as described previously (Resing et al., 1984).
Isolation of stratum corneum
The epidermis was suspended overnight at 4 C in 0.5% trypsin (TRL grade;
Worthington Biochemical Company), rinsed in 20 mM PBS, pH 7.4, and
0.15 M NaCl overnight, rinsed in distilled water, retreated with fresh 0.5%
trypsin in PBS for 2 h at RT, and rinsed in distilled water.
Epidermal lipid analysis
Lipids were extracted from desiccated epidermis and analyzed by TLC as
described previously (Law et al., 1995).
cDNA array analysis
Array analysis was performed essentially as described previously (Tera-
moto et al., 2003). In brief, Cy-3– and Cy-5–labeled hybridization probes
were generated from RNA isolated from neonate Matriptase/MT-SP1
 / 
and littermate control epidermis and used to screen mouse Mm-GEM2-
v10p2_111602 cDNA arrays (NCI Microarray Facility, Gaithersburg, MD).
Hybridized arrays were scanned (GenePix 4000A; Axon Instruments) and
analyzed with GenePix Pro v3.0 (Axon Instruments) as described in the
manufacturer’s manual. The hybridization was repeated three times with
independent sets of Matriptase/MT-SP1
 /  and littermate control epider-
mis, reversing the fluorophores in one experiment. The complete list of the
8590 unique cDNAs included on the array is available upon request.
Protein identification by mass spectrometric peptide mapping
Proteins were separated by SDS-PAGE under reducing conditions. The gel
was stained with amido black, and gel pieces in the region of interest were
excised, rinsed, reduced, and alkylated before in-gel digestion with trypsin
and analysis by MALDI mass spectrometry using a mass spectrometer (Per-
Septive Voyager DE-RP; Applied Biosystems). Protein identification was
performed by submitting the tryptic peptide masses for sequence database
searches using MS-Fit/MS-Digest/ProteinProspector software (The Mass
Spectrometry Facility of the University of California, San Francisco, CA) and
the National Center for Biotechnology Information Entrez Protein database.
Western blot analysis
Western blot analysis was performed as described previously (Netzel-
Arnett et al., 2002) using rabbit antibodies to mouse keratin-1, -5, -10, and
-14, filaggrin, loricrin (Covance), claudin-1, profilaggrin (Zymed Laborato-
ries), calpain-1 (Triple Point Biologics, Inc.), or protein phosphatase 2A
(Upstate Biotechnology). Antibodies bound to the membrane were de-
tected with alkaline phosphatase–conjugated porcine anti–rabbit or goat
anti–mouse IgG (DakoCytomation).
RNA preparation and Northern blot analysis
RNA from neonatal skin was isolated and subjected to Northern blot anal-
ysis as described previously (List et al., 2002).
Skin grafting
Full-thickness dorsal skin grafts from neonate donor mice were transplanted
onto athymic nude recipient mice as rectangular, 3–4-cm
2 split-thickness
dorsal grafts. The grafts were secured with silk sutures, and Polysporin anti-
biotic ointment (Warner Lambert) was applied topically after surgery.
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